NASDAQ:BPTH

Bio-path Holdings Stock Signals

etoro logo Buy BPTH
*Your capital is at risk
$0.0860
-0.0115 (-11.78%)
At Close: Nov 17, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.078 2 days ( 11.78 % )
Last Price $0.0860 -11.78 %
High/ Low $0.0804 - $0.0940 8.59%
Chg 7 Days -1.26 % $0.0871 $0.0860
Chg 30 Days 33.96 % $0.0642 $0.0860
Chg 12 mos -89.38 % $0.81 $0.0860
Trend - 3 mos -18.36 % Width: 133.08 %
Trend - 12 mos -54.10 % Width: 593.28 %
Pred. range - 3 mos $0.0332 - $0.0774 -61.39 % - -10.00 %
Pred. range - 12 mos N/A - $0.330 -100.00 % - 283.39 %
Short MA avg 3 mos Buy Nov 13, 2025 - 3 days
Long MA avg 3 mos Buy Oct 17, 2025 - 22 days
Short/Long MA avg 3 mos Buy Oct 21, 2025 - 20 days
Short MA avg 12 mos Sell Nov 14, 2025 - 2 days
Long MA avg 12 mos Buy Jul 16, 2025 - 88 days
Short/Long MA avg 12 mos Sell Jul 17, 2025 - 87 days
Pivot Short Sell Oct 27, 2025 - 16 days
Bollinger Buy Aug 15, 2025 - 66 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT BIO-PATH HOLDINGS
Bio-Path Holdings
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE